sellWeak cluster of 210b5-1 plan
Julie Diane Jolley sold $76k of EHAB
EVP of Home Health Operations at Enhabit, Inc.. 5,586 shares at an average of $13.63, traded Mar 9, 2026, filed Mar 11, 2026.
Warning score
11Value
$76k
5,586 shares
Holdings after
137,130
-4% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +8Trade size$76k at market
- 0Share of holdings soldSold 3.9% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001933957-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | SOpen-market sale Common Stock10b5-1 | -2,793 | $13.63 | $38k | 139,923 | Mar 11, 2026 |
| Mar 10, 2026 | SOpen-market sale Common Stock10b5-1 | -2,793 | $13.63 | $38k | 137,130 | Mar 11, 2026 |
Related signals
Other insiders at Enhabit, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Enhabit, Inc. | Collin McQuiddy Chief Accounting Officer | $19k 1,403 shares | -26% | |
| 33Weak | EHABbuy Enhabit, Inc. | Ryan Solomon Chief Financial Officer | $76k 10,000 shares | +5% | |
| 35Weak | EHABsell Enhabit, Inc. | Collin McQuiddy Chief Accounting Officer | $9,404 1,096 shares | -100% | |
| 34Weak | Enhabit, Inc. | Jeffrey Bolton director | $35k 4,000 shares | +4% | |
| 40Moderate | Enhabit, Inc. | Stuart M McGuigan director | $132k 15,000 shares | +47% | |
| 26Weak | EHABbuy Enhabit, Inc. | Jeffrey Bolton director | $77k 10,000 shares | +12% | |
| 43Moderate | Enhabit, Inc. | Jeffrey Bolton director | $83k 10,000 shares | +24% | |
| 26Weak | Enhabit, Inc. | Erin Hoeflinger director | $18k 2,000 shares | +7% | |
| 38Weak | Enhabit, Inc. | Jeffrey Bolton director | $82k 10,000 shares | +31% | |
| 15Weak | EHABsell Enhabit, Inc. | Ronald Leroy Langham JR EVP Clinical Excel. & Strategy | $5,586 634 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.